Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/2/25 16:47 | 12/13/24 | NVAX | Health | BioPrd | Biological Products, (No Diag | King Rachel K. | MD | D | S | -37 | 9.02 | 0 | -4 | -22 | 15 | D | |||||||||||||||
1/2/25 16:44 | 12/24/24 | NVAX | Health | BioPrd | Biological Products, (No Diag | Young James F | MD | D | S.m | -82 | 8.22 | 0 | -10 | -16 | 52 | D | |||||||||||||||
6/25/24 16:12 | 6/21/24 | NVAX | Health | BioPrd | Biological Products, (No Diag | Young James F | MD | D | S | -106 | 14.09 | 0 | -8 | -11 | 62 | D | |||||||||||||||
6/21/24 16:21 | 6/18/24 | NVAX | Health | BioPrd | Biological Products, (No Diag | Young James F | MD | D | S | -103 | 13.72 | 0 | -8 | -10 | 69 | D | |||||||||||||||
6/20/24 17:08 | 6/17/24 | NVAX | Health | BioPrd | Biological Products, (No Diag | Dubovsky Filip | MD | O | P,R,D | S.d | -201 | 14.47 | 0 | -14 | -17 | 67 | D | ||||||||||||||
5/15/24 21:15 | 5/14/24 | NVAX | Health | BioPrd | Biological Products, (No Diag | Dubovsky Filip | MD | O | P,R,D | S.d | -658 | 13.90 | 0 | -47 | -55 | 39 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |